Insights

On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding  allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.

The clean energy transition isn’t a zero-sum game – it’s a team effort.  And one player is stepping back into the spotlight with renewed...

As deal activity shows signs of rebounding in 2025, investors are bracing for an increase in M&A-related disputes globally, and Latin...

This year, U.S. trade policy has undergone a dramatic shift, driven by a series of presidential proclamations that have raised tariff rates sharply.

One of the most common questions we get from clients is, “What is the future of the Trump administration’s tariff strategy?”

In this article we will provide an overview of how qubits are implemented in real, physical systems to make quantum computing possible.

Less than five months into the new administration, we have already seen more than 50 tariff proclamations.

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for metabolic disorders, particularly type 2 diabetes and obesity.

This blog discusses the regulatory requirements that apply to risk-bearing entities in Massachusetts, including recent updates introduced by Chapter 343 of the Massachusetts Acts of 2024.